Latest Australia News

Syrah Resources is set to receive a further US$15 million from the US International Development Finance Corporation before the end of October, providing working and sustaining capital for its Balama graphite operation. The funding comes with a temporary waiver of existing loan defaults, new warrants and no guarantee of further disbursements.

Electro Optic Systems has expanded its defence pipeline sharply, with an unconditional A$717 million order book and a conditional Kuwait contract that could add about A$700 million. The opportunity comes with substantial guarantee, working-capital and export-licensing requirements.

Saunders International has secured four multi-year water appointments and framework arrangements across four states, giving it access to approximately $2 billion in forecast capital works programs over five years. The opportunities are strategically significant, but no work volumes are guaranteed and revenue contribution is not expected until FY2027.

Lightning Minerals has secured A$100,000 in non-dilutive cash and a funded 400-metre drilling commitment by granting Kincora Copper a nine-month option over six Lachlan Fold Belt licences. The deal could deliver another A$350,000, but only if Kincora exercises the option, approvals are obtained and a key tenement is renewed.

Mayne Pharma’s unaudited first-quarter revenue fell 2% to A$95.7 million, while underlying EBITDA dropped 52% as generic competition hit Dermatology. Strong prescription growth in Women’s Health and DistributeRx offered a partial counterweight, alongside progress on key legal disputes.

Marmota has extended the high-grade Greenewood gold system north and to depth, with mineralisation now traced across more than 2km of strike. The latest assays include 8 metres at 11.5 grams per tonne gold, although the results are still based mainly on initial 4-metre composites and do not yet establish a mineral resource.

Carnaby Resources shareholders supplied strong proxy backing for Evolution Mining’s proposed takeover, with 94.99% of proxy votes cast in favour. The final poll result was not included in the announcement, leaving Court approval as the next major hurdle if the scheme passes.

Cochlear has reaffirmed FY27 underlying net profit guidance of $330 million to $350 million after a disappointing FY26, while pointing to strong Nexa adoption and progress on fully implantable hearing technology. The company is cutting fixed costs and expanding medical referral pathways as it seeks to convert a large pool of untreated adult hearing loss into growth.

Biome Australia has reported record pharmacy sell-through, further market-share gains and positive operating cash flow as it begins manufacturing Activated Probiotics domestically. The quarter also moved its China expansion and BMB18 clinical trial closer to key execution milestones.

Sarytogan Graphite has completed a 50,000-tonne-a-year upstream graphite DFS and extended copper porphyry exploration in Kazakhstan, but held only A$1.015 million in cash at quarter end. The company estimates that balance represents 0.88 quarters of funding at its recent spending rate, leaving project financing and potential capital raising firmly in focus.

Capricorn Metals has reported further high-grade gold intersections at Mt Gibson, with Lexington mineralisation extending beyond current pit and underground designs. The results support a planned maiden underground resource at Lexington later this quarter, but remain exploration results rather than an Ore Reserve.

Dynamic Metals is reshaping its Western Australian portfolio through two gold asset sales worth up to A$4.15 million, while fresh soil sampling at Widgiemooltha creates a near-term assay catalyst. The company ended September with A$1.568 million in cash, equivalent to an estimated 2.7 quarters of funding at the reported rate of outgoings.